Evidence map›Paper›PMID 39439719›Full record

ArticleBiotechnologia2024

Induction of an immune response by a nonreplicating adenoviruses-based formulation versus a commercial pseudo-SARS-CoV-2 vaccine.

Joanna Baran, Łukasz Kuryk, Mariangela Garofalo, Katarzyna Pancer, Magdalena Wieczorek, Michalina Kazek, Monika Staniszewska

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biotechnologia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joanna BaranCentre for Advanced Materials and Technologies, Warsaw University of Technology, Warszawa, Poland.
Łukasz KurykNational Institute of Public Health National Institute of Hygiene (NIH) - National Institute of Research, Warszawa, Poland.
Mariangela GarofaloDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Katarzyna PancerNational Institute of Public Health National Institute of Hygiene (NIH) - National Institute of Research, Warszawa, Poland.
Magdalena WieczorekNational Institute of Public Health National Institute of Hygiene (NIH) - National Institute of Research, Warszawa, Poland.
Michalina KazekCentre for Advanced Materials and Technologies, Warsaw University of Technology, Warszawa, Poland.
Monika StaniszewskaCentre for Advanced Materials and Technologies, Warsaw University of Technology, Warszawa, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Screening for effective vaccines requires broad studies on their immunogenicity

Indexed as

adenovirusesCD cellsimmune responseSARS-CoV-2vaccines

Identifiers

PMID39439719
PMCPMC11492889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.